(Q33554543)

28 July 2017

title

The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up (English)

1 reference

28 July 2017

0 references

1 reference

Baltus JA

1

1 reference

28 July 2017

Boersma JW

series ordinal

2

1 reference

28 July 2017

Hartman AP

series ordinal

3

1 reference

28 July 2017

Vandenbroucke JP

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 August 1983

1 reference

Annals of the Rheumatic Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

42

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

368-373

1 reference

COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

The association of rheumatoid arthritis with plasma cell and lymphocytic neoplasms

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Immunosuppression and cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Death Rate and Causes of Death in Patients with Rheumatoid Arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Carcinoma of the Urinary Bladder in Patients Receiving Cyclophosphamide

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Acute leukemia in rheumatoid arthritis treated with cytotoxic agents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Controlled trial of cyclophosphamide in rheumatoid arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Second malignant neoplasms associated with immunosuppressive medications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Lymphoid neoplasia following connective tissue disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Duration of improvement of rheumatoid arthritis after good response to cyclophosphamide treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Results and long-term risks of immuno-suppressive treatment in chronic juvenile arthritis. Apropos of 40 cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Post-therapeutic acute leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Malignancies associated with immunosuppressive or cytotoxic therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Cytotoxic Agents in the Treatment of Rheumatoid Arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Acute leukaemias after treatment using cytotoxic agents for rheumatological purpose. 19 cases among 2006 patients(author's transl)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Cyclophosphamide and malignancy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Immunosuppressive Therapy in Rheumatic Disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1001244

Leukemia or lymphoma occurring subsequent to an autoimmune disease

28 July 2018

1 reference

12 December 2020

Survivorship and Death in Rheumatoid Arthritis

1 reference

12 December 2020

Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis

1 reference

12 December 2020

Cytotoxic drugs in treatment of nonmalignant diseases

1 reference

12 December 2020

Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

Evolution of patients with rheumatoid arthritis treated with immunosuppressive agents between 1965 and 1973

1 reference

12 December 2020

Development of reticulum cell sarcoma during cyclophosphamide therapy

1 reference

12 December 2020

Long-term cyclophosphamide therapy in rheumatoid arthritis

1 reference

12 December 2020

The association of immune disease and malignant lymphoma

1 reference

12 December 2020

Causes of death in autopsied RA patients

1 reference

12 December 2020

Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis

1 reference

12 December 2020

Length of life and cause of death in rheumatoid arthritis

1 reference

12 December 2020

Characterization of the immunocompetent cells of rheumatoid synovium from tissue sections and eluates

1 reference

12 December 2020

Mortality among arthritics

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.42.4.368

1 reference

28 July 2017

1 reference

28 July 2017

1 reference